Bitte beachten Sie: Diese Stellenanzeige ist nicht mehr aktiv.
Entdecken Sie hier weitere Stellenanzeigen auf academics, dem führenden Stellenmarkt für Wissenschaft und Forschung. Um regelmäßig per E-Mail über passende Stellen informiert zu werden, können Sie sich jederzeit kostenlos registrieren.
Independent Junior Group Leader (f/m/d) in Single Cell Approaches for Personalized Medicine
Veröffentlicht am(vor 52 Tagen)
Bewerbungsende(vor 17 Tagen)
Berliner Institut für Gesundheitsforschung (BIG) - Berlin Institute of Health (BIH)Berlin
The Berlin Institute of Health (BIH) is a biomedical research institution focusing on translational research and precision medicine.
BIH uses a systems medicine approach to develop innovative options for prediction, prevention and advanced therapies for progressive
diseases in order to improve patients' health and quality of life. To realize its innovative plans in translational research, BIH builds
on the strengths and expertise of its founding institutions Charité – Universitätsmedizin Berlin and Max Delbrück Center for Molecular
Medicine in the Helmholtz Association (MDC). The Berlin Institute for Medical Systems Biology (BIMSB), located in the center of Berlin,
is a strategic expansion of the MDC to establish major expertise in the field of Systems and Single Cell Biology.
In order to strengthen translational research within the dynamic field of single cell approaches and to give promising researchers
the possibility of independent scientific work, BIH and MDC jointly invite applications for the following positions:
Junior Group Leaders in Single Cell Approaches
for Personalized Medicine
with possible tenure as full professor
The 3 independent junior research groups are to be a central element within the new Clinical Research Focus on »Single Cell
Approaches for Personalized Medicine« jointly established by BIH, MDC and Charité bridging basic and clinical research. Each junior
research group will closely collaborate with a clinical department at the Charité on a specific disease, disease area or disease
Possible research areas include, but are not limited to cancer, inflammation, re-/degeneration, neurodegenerative, cardiovascular
or rare diseases.
As leaders of the junior research group it is expected that successful candidates will conduct independent research at the MDC / BIMSB in close collaboration with partnering clinical units at the Charité and are prepared to foster technological development
for clinical translation.
We invite applications from outstanding scientists with demonstrated expertise in single cell molecular profiling, cell lineage
and/or imaging. We are specifically looking for candidates who investigate mechanisms of human disease progression at
the single cell level or who develop novel methods for early diagnosis and effective interception of disease.
Applicants must hold a doctorate (Ph.D. and/or M.D.) in the life sciences or related areas
Applicants must have an excellent track record demonstrating highly successful research and translational relevance
Applicants should have demonstrable working experience in an interdisciplinary research environment
It is desirable that applicants have got first experiences in clinical research or are highly motivated for it
Applicants are expected to have excellent communication skills and leadership potential
BIH, Charité and MDC are committed to excellence through diversity and in particular to increasing the proportion of women among the
scientific staff. Applications from women are explicitly encouraged. Equally qualified applicants with disabilities will be given preference.
BIH and MDC offer an attractive start-up package including the group leader's position (salary according to the German public
salary scheme TVöD Bund/Ost), start-up investment, one postdoc, one PhD student, one technician, as well as fixed annual
and additional opportunities to recruit students from the MDC's PhD or Fellowship Programs. Laboratories of the
successful candidates are equipped with state-of-the-art facilities and are located in the new BIMSB building, within walking
from the Charité campus in Berlin Mitte.
The appointment of successful candidates is handled according to the BIH tenure option scheme:
Initial appointment is for 5 years with a possible extension for additional 2 years depending
on a positive evaluation of the research group in the 4th year
Based on a scientific evaluation in the 6th year, BIH and its partners will decide on a tenured
appointment of the candidate for a full professorship (Salary group: W3 BBesG).
How to apply?
Applications will be accepted via our online application portal at portal.bihealth.de/portal/SitePages/Portal.aspx. Please upload your
full application in English by 26.11.2019. Short-listed candidates should be prepared to attend the symposium for the positions in
January 2020, during which they will have the opportunity to present their achievements and research plans to a selection committee.
For detailed information on the application and selection process please visit https://www.bihealth.org/en/offers/available-positions/.
Inquiries about the positions should be directed to Prof. Dr. Nikolaus Rajewsky, BIMSB Scientific Director, email@example.com Formal inquiries regarding the application process should be addressed to Dr. Albrecht Blümel, firstname.lastname@example.org
Nach der Registrierung können Sie Ihr Profil anpassen.
Sie können Ihre Anmeldung zum Newsletter jederzeit widerrufen, bspw. per E-Mail an email@example.com. Wir verwenden Ihre E-Mailadresse auch, um Ihnen Werbung für ähnliche Angebote der ZEIT Verlagsgruppe zuzusenden. Dieser Verwendung können Sie jederzeit widersprechen. Mit Ihrer Anmeldung erklären Sie sich mit unseren AGB einverstanden und nehmen die Datenschutzbestimmungen zur Kenntnis.
Um unsere Webseite optimal gestalten und fortlaufend verbessern zu können, verwenden wir Cookies. Durch die weitere Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Weitere Informationen sowie Hinweise dazu, wie Sie die Speicherung der Cookies verhindern können, finden Sie in unserer Datenschutzerklärung.